Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    Tested chemotherapy drugs are as follows:

    Test Chemotherapy drug & ConcentrationAverage Breakthrough Detection Time (Minutes)
    Carmustine (BCNU)(3.3 mg/ml)12.1 min.
    Cyclophosphamide (Cytoxan) (20.0 mg/ml)>240 min.
    Doxorubicin Hydrichloride (2.0mg/)>240 min.
    Etoposide (Toposar) (20.0mg/ml)>240 min.
    Fluorouracil (50.0mg/ml)>240 min.
    Methotrexate (25.0 mg/ml)>240 min.
    Paclitaxel (Taxol) (6.0 mg/ml)>240 min.
    Thiotepa(10.0 mg/ml)10.1 min.
    Vincristine Sulfate(1.0 mg/ml)>240 min.
    Cisplatin(1.0 mg/ml)>240 min.
    Dacarbazine(10 mg/ml)>240 min.
    Mitomycin C(0.5 mg/ml)>240 min.

    Please note that the following drugs have extremely low permeation times: Carmustine (BCNU): 12.1 minutes and Thiotepa:10.1 minutes.

    Warning: Do not use with Carmustine or Thiotepa

    Fentanyl Citrate & ConcentrationMinimum Breakthrough Detection Times
    Fentanyl Citrate Injection(100 mcg/2ml)>240 min.
    Device Description

    The Nitrile Patient Examination Gloves with Hyaluronic Acid Blue Colored and Tested for Use with Chemotherapy Drugs and Fentanyl citrate. Aka Synguard C+ Nitrile Exam Gloves are non-sterile, single use only, disposable, powder free examination gloves. The glove is made of nitrile butadiene rubber. Chlorination is applied to the inner surface of the glove to make donning easy. Characteristic:

    • Ambidextrous with beaded cuff and straight fingers
    • Finger-textured,
    • Blue colored
    • Containing Hyaluronic Acid coating.
    • Six (6) sizes extra-small, small, medium, large, extra-large and XXL.
    • Tested against chemotherapy drugs and fentanyl citrate.

    The gloves are designed to meets the specifications of ASTM D6319-19, Standard Specification for Nitrile Examination Gloves for Medical Application.

    AI/ML Overview

    The provided document is a 510(k) summary for a medical device (nitrile patient examination gloves with hyaluronic acid) and details the performance testing against established standards.

    Here's a breakdown of the acceptance criteria and study information, based on the provided text:

    1. A table of acceptance criteria and the reported device performance:

    The document includes a "Technological Characteristics Comparison Table" (pages 7-9) that serves this purpose. It compares the applicant's device to a predicate device (K200671). The "Acceptance Criteria" column effectively outlines the criteria, and the "Anhui Intco Medical Products Co., Ltd. Nitrile Patient Examination Gloves..." column shows the reported device performance.

    CharacteristicsAcceptance Criteria (from predicate/standards)Reported Device Performance (Anhui Intco Medical Products Co., Ltd.)Comparison Conclusions
    Product CodeLZA, LZC, OPJ, QDOLZA, LZC, OPJ, QDO(Implicitly "Same")
    Intended useA powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs as per ASTM D6978-05.A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.Same
    Material usedNitrileNitrileIdentical
    ColorBlueBlueSame
    Single useSingle UseYesSame
    Non SterileNon SterileNon SterileSame
    Other(Implicit: Additives related to coating)Hyaluronic Acid coated on the donning surfaceDifferent(1)
    DimensionsOverall Length (mm): For XS, S, Min 220mm; For M,L,XL,XXL Min 230mm. Width (± 10mm): XS=70mm, S=80mm, M=95mm, L=110mm, XL=120mm, XXL=130mm. Thickness at Palm (mm) Min: 0.05mm. Thickness at Finger Tip (mm) Min: 0.05mm.Complies with ASTM D6319-19: X Small 70±10, Small 80 ±10, Medium 95±10, Large 110 ±10, X large 120 ±10, XX Large 130 ±10. Thickness: Palm - 0.05mm min., Finger - 0.05 mm min.Similar
    Physical propertiesBefore Ageing: Tensile Strength (MPa) = 14min, Ultimate Elongation (%) = 500min. After Aging: Tensile Strength (MPa) = 14min, Ultimate Elongation (%) = 400min.Meets ASTM D6319-19: Tensile Strength: Before Aging 14 MPa, min. After Aging 14 MPa, min. Elongation: Before Aging 500% min. After Aging 400% min.Meets the criteria
    Freedom from pinholesAQL 2.5, Inspection Level G-1In accordance with ASTM D6319-19 and ASTM D5151-19, G-1, AQL 2.5Meets the criteria
    Residual PowderLess than 2mg per glove ASTM D 6124-06Average powder residue < 2mg per gloveMeets the criteria
    Primary Skin Irritation TestISO10993-10:2010Under the conditions of this study, the test article was a non-irritant.Same
    Dermal Sensitization AssayISO10993-10:2010Under the conditions of this study, the test article was a non-sensitizer.Same
    Acute systemic toxicityISO 10993-11:2017Under the conditions of this study, No evidence of acute systemic toxicitySame
    Resistance against Chemotherapy DrugsStandards Practice for Assessment of resistance of Medical Glove to Permeation by Chemotherapy drugs ASTM D6978-05(2013)1) Carmustine (BCNU) (3.3 mg/ml), Breakthrough time: 12.1 min.2) Cyclophosphamide (Cytoxan), (20.0 mg/ml), Breakthrough time: >240 min.3) Doxorubicin Hydrochloride (2.0mg/), Breakthrough time: >240 min.4) Etoposide (Toposar) (20.0mg/ml), Breakthrough time: >240 min.5) Fluorouracil (50.0mg/ml), Breakthrough time:>240 min.6) Methotrexate (25.0 mg/ml), Breakthrough time: >240 min.7) Paclitaxel (Taxol) (6.0 mg/ml), Breakthrough time: >240 min.8) Thiotepa, Breakthrough time: 10.1 min.9) Vincristine Sulfate (1.0 mg/ml), Breakthrough time:>240 min.10) Cisplatin (1.0 mg/ml), Breakthrough time:>240 min.11) Dacarbazine (10 mg/ml), Breakthrough time:>240 min.12) Mitomycin C (0.5 mg/ml), Breakthrough time:>240 min.13) Fentanyl Citrate Injection (100 mcg/2ml), Breakthrough time:>240 min.Similar

    2. Sample size used for the test set and the data provenance:

    The document does not explicitly state the sample sizes for the test sets in the non-clinical tests (e.g., how many gloves were tested for pinholes, how many animals were used for biocompatibility testing). However, it refers to industry standards like ASTM and ISO, which typically define appropriate sample sizes for such tests.

    • Provenance: The tests were performed in accordance with international standards (ASTM, ISO). The manufacturing company is Anhui Intco Medical Products Co., Ltd. located in Anhui, China. The testing itself is presented as non-clinical testing to demonstrate performance against these standards. The testing format suggests a retrospective evaluation against pre-defined performance criteria.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):

    This information is not applicable as the document describes performance testing of physical characteristics of gloves against codified standards (ASTM, ISO), not an AI device or a diagnostic device requiring expert interpretation of results to establish ground truth. The "ground truth" here is the pass/fail criteria defined by the standards.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

    This is not applicable as the document describes performance testing of physical characteristics against codified standards. There is no subjective adjudication process for the test results.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    This is not applicable. The device is a medical glove, not an AI-assisted diagnostic tool.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

    This is not applicable. The device is a medical glove, not an algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):

    The "ground truth" for the performance tests conducted (e.g., tensile strength, pinholes, chemical permeation, biocompatibility) is established by industry standards and test methods (ASTM D6319-19, ASTM D5151-19, ASTM D6124-06, ASTM D6978-05, ISO 10993 series). These standards define the acceptable range or threshold for a given characteristic to be considered compliant.

    8. The sample size for the training set:

    This is not applicable. The device is a medical glove, not an AI model that requires a training set.

    9. How the ground truth for the training set was established:

    This is not applicable.

    Ask a Question

    Ask a specific question about this device

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Powder Free Nitrile Examination Glove 2.8 Blue Color, Non-Sterile, and Tested for Use with Chemotherapy Drugs, Fentaryl Citrate, and Select Other Drugs is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.

    These gloves were tested for use with Chemotherapy Drugs, Fentanyl Citrate, and Select Other Drugs as per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    Device Description

    Powder Free Nitrile Examination Glove 2.8 Blue Color, Non-Sterile, and Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, and Select Other Drugs are Class I Patient Examination Gloves and Specialty Chemotherapy Gloves. They are ambidextrous and come in different sizes - Extra Small, Small, Medium, Large, Extra Large, Extra Extra Large. Gloves meet the specification of ASTM D6319- 19 and have been tested for resistance to permeation by chemotherapy drugs, Fentanyl Citrate, and select other drugs as per ASTM D6978-05(2019). The gloves are single use, disposable, and provided non-sterile.

    AI/ML Overview

    The provided documentation describes the non-clinical performance testing of a medical device, specifically Powder Free Nitrile Examination Glove 2.8 Blue Color, Non-Sterile, and Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, and Select Other Drugs (K233598). The study aims to demonstrate that the device meets acceptance criteria and is substantially equivalent to a predicate device (K223713).

    Here's an analysis of the acceptance criteria and the study proving the device meets them, based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria are primarily defined by various ASTM and ISO standards, and the reported performance indicates that the device passed these criteria. The key performance metrics are related to physical dimensions, physical properties (tensile strength, elongation), freedom from holes, residual powder, permeation by chemotherapy drugs and fentanyl citrate, and biocompatibility.

    Methodology / Test PerformedAcceptance CriteriaReported Device Performance (Result)
    ASTM D6319-19: Physical Dimensions (Length)Minimum 220mm for size XS and S; 230mm for size M, L, XLPass
    ASTM D6319-19: Physical Dimensions (Palm Width)XS: 70±10mm; S: 80±10mm; M: 95±10mm; L: 110±10mm; XL: 120±10mm; XXL: 130±10mmPass
    ASTM D6319-19: Physical Dimensions (Thickness)Finger: 0.05mm (min); Palm: 0.05mm (min)Pass
    ASTM D6319-19, ASTM D412-16 (2021): Physical PropertiesBefore aging: 14MPa, min (Tensile Strength); 500%, min (Ultimate Elongation) After aging: 14MPa, min (Tensile Strength); 400%, min (Ultimate Elongation)Pass
    ASTM D6319-19, ASTM D5151-19: Water Leak TestG-I, AQL 2.5 (ISO 2859-1)Pass
    ASTM D6319-19, ASTM D6124-06 (2017): Powder ResidueMax 2mg/glovePass
    ASTM D6978-05 (2019): Permeation by Chemotherapy DrugsMost Drugs: >240 minutes (e.g., Bendamustine HCl, Bleomycin sulfate, Carboplatin, etc.) Carmustine (3.3 mg/ml): 1.7 minutes ThioTepa (10 mg/ml): 0 minutesMeets stated values (see table)
    ASTM D6978-05 (2019): Permeation by Fentanyl CitrateFentanyl Citrate Injection (100 mcg/2ml): >240 minutes>240 min.
    ASTM D6978-05 (2019): Permeation by Select Other DrugsChloroquine (50mg/ml), Cyclosporin A (100mg/ml), Retrovir (10 mg/ml): >240 minutes>240 min.
    ISO 10993-10:2021: Skin SensitizationNo Skin SensitizationThe sample extract elicits no sensitization reactions under the test conditions.
    ISO 10993-23:2021: IrritationNo Skin IrritationUnder the conditions of this study, the irritation response category of the test article is classified as Negligible for polar extract and Negligible for non-polar extract.
    ISO 10993-11:2017: Acute Systemic Toxicity StudySubject showed no adverse biological reactionNo death or acute systemic toxicity was observed in the mice which received injection of the extract.

    Important Note on Chemotherapy Drugs: The document explicitly states: "Please note that the following drugs have extremely low permeation times: Carmustine (BCNU): 1.7 minutes and Thiotepa: 0 minute. Warning: Do not use with Carmustine and Thiotepa." This means that while the glove was tested against these drugs, its performance for them is below the typical acceptable threshold for chemotherapy gloves (which is usually >240 minutes for other drugs), and this is a critical aspect of its labeling and intended use.

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size for Test Set: The document does not explicitly state the exact sample sizes (number of gloves or individual tests) used for each performance test. It only refers to the standards (e.g., ASTM D6319-19, ASTM D6978-05), which would specify the required sample sizes for testing. For instance, ASTM D6319-19 defines AQL (Acceptable Quality Level) for certain tests (e.g., G-I, AQL 2.5 for water leak test), which implies specific sampling plans.
    • Data Provenance: The tests were non-clinical performance studies. The data provenance is linked to the manufacturer, Anhui Intco Medical Products Co., Ltd., China. The tests are described as having been "conducted to verify that the proposed device met all design specifications," implying a prospective testing approach within a laboratory setting, rather than retrospective analysis of existing data.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    This information is not applicable to this type of device and study. The "ground truth" for glove performance (e.g., tensile strength, breakthrough time, freedom from holes) is established through standardized laboratory testing methods (ASTM, ISO), not through expert consensus or clinical judgment of images or patient data. The results are objective, measurable physical properties and chemical resistance.

    4. Adjudication Method for the Test Set

    This information is not applicable. Adjudication methods (like 2+1, 3+1) are used in clinical studies, particularly in image interpretation, where human readers might disagree, and a consensus or majority opinion is needed to establish ground truth. For the physical and chemical performance tests of gloves, the results are quantitative and objective, determined by laboratory equipment and standardized procedures.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done

    No, a Multi Reader Multi Case (MRMC) comparative effectiveness study was not done. This type of study is relevant for AI-powered diagnostic devices where human readers interpret medical images or data. The device in question is a medical glove, a physical barrier, not a diagnostic tool requiring human interpretation with or without AI assistance.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    No, this is not applicable. The device is a physical product (a glove), not an algorithm or software. Therefore, there is no "algorithm only" performance to evaluate. The tests performed are on the physical properties and chemical resistance of the glove itself.

    7. The Type of Ground Truth Used

    The ground truth used for these tests is based on:

    • Standardized Measurement: Directly measurable physical properties (e.g., length, width, thickness, tensile strength, elongation, residual powder).
    • Controlled Chemical Permeation Tests: Breakthrough detection times for specific hazardous chemicals (chemotherapy drugs, fentanyl citrate).
    • Biological Testing: In-vivo (animal) and in-vitro tests for biocompatibility (skin irritation, sensitization, acute systemic toxicity) as defined by ISO standards.

    Essentially, the "ground truth" is defined by the established and validated protocols of the cited ASTM and ISO standards for testing medical gloves.

    8. The Sample Size for the Training Set

    This information is not applicable. This submission is for a physical medical device (a glove) that undergoes manufacturing processes and performance testing, not an artificial intelligence (AI) or machine learning (ML) algorithm. Therefore, there is no "training set" in the context of AI/ML.

    9. How the Ground Truth for the Training Set Was Established

    This information is not applicable as there is no "training set" for this type of device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1